Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group.

Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H
Clin J Am Soc Nephrol. 2009 4 (1): 39-47

PMID: 19073787 · PMCID: PMC2615712 · DOI:10.2215/CJN.02310508

MeSH Terms (24)

Administration, Oral Adolescent Age Factors Body Surface Area Canada Child Child, Preschool Drug Resistance Female Glomerular Filtration Rate Glomerulosclerosis, Focal Segmental Humans Immunosuppressive Agents Kidney Male Proteinuria Rosiglitazone Serum Albumin Steroids Thiazolidinediones Time Factors Treatment Outcome United States Young Adult

Connections (2)

This publication is referenced by other Labnodes entities: